BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31435238)

  • 1.
    Al-Moghrabi NM
    J Taibah Univ Med Sci; 2017 Jun; 12(3):189-193. PubMed ID: 31435238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
    Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
    Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.
    Wong EM; Southey MC; Fox SB; Brown MA; Dowty JG; Jenkins MA; Giles GG; Hopper JL; Dobrovic A
    Cancer Prev Res (Phila); 2011 Jan; 4(1):23-33. PubMed ID: 20978112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.
    Pang D; Zhao Y; Xue W; Shan M; Chen Y; Zhang Y; Zhang G; Liu F; Li D; Yang Y
    Med Oncol; 2012 Sep; 29(3):1561-8. PubMed ID: 22076508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated
    Al-Showimi M; Al-Yousef N; Alharbi W; Alkhezayem S; Almalik O; Alhusaini H; Alghamdi A; Al-Moghrabi N
    Oncol Lett; 2022 Aug; 24(2):276. PubMed ID: 35782895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype.
    Snell C; Krypuy M; Wong EM; ; Loughrey MB; Dobrovic A
    Breast Cancer Res; 2008; 10(1):R12. PubMed ID: 18269736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters.
    Al-Moghrabi N; Al-Showimi M; Al-Yousef N; Al-Shahrani B; Karakas B; Alghofaili L; Almubarak H; Madkhali S; Al Humaidan H
    Clin Epigenetics; 2018 Jul; 10(1):99. PubMed ID: 30049288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of BRCA1 Gene Promoter Methylation Status in Sporadic Breast Cancer Patients in Southwest of Iran.
    Hassani H; Talaiezadeh A; Tahmasebi Birgani M; Bijanzadeh M
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):811-817. PubMed ID: 36974532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
    Hasan TN; Leena Grace B; Shafi G; Syed R
    Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA methylation assessment of 'BRCA1-like' early-onset breast cancer: Data from the Australian Breast Cancer Family Registry.
    Scott CM; Wong EM; Joo JE; Dugué PA; Jung CH; O'Callaghan N; Dowty J; Giles GG; Hopper JL; Southey MC
    Exp Mol Pathol; 2018 Dec; 105(3):404-410. PubMed ID: 30423315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.
    Hsu NC; Huang YF; Yokoyama KK; Chu PY; Chen FM; Hou MF
    PLoS One; 2013; 8(2):e56256. PubMed ID: 23405268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.
    Iwamoto T; Yamamoto N; Taguchi T; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 129(1):69-77. PubMed ID: 20882403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
    Bosviel R; Garcia S; Lavediaux G; Michard E; Dravers M; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Cancer Epidemiol; 2012 Jun; 36(3):e177-82. PubMed ID: 22402307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.
    Wang T; McCullough LE; White AJ; Bradshaw PT; Xu X; Cho YH; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
    Cancer; 2019 Nov; 125(21):3836-3844. PubMed ID: 31402456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.
    Prajzendanc K; Domagała P; Hybiak J; Ryś J; Huzarski T; Szwiec M; Tomiczek-Szwiec J; Redelbach W; Sejda A; Gronwald J; Kluz T; Wiśniowski R; Cybulski C; Łukomska A; Białkowska K; Sukiennicki G; Kulczycka K; Narod SA; Wojdacz TK; Lubiński J; Jakubowska A
    Int J Cancer; 2020 Mar; 146(5):1293-1298. PubMed ID: 31469414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
    Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
    Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
    Scott CM; Joo JE; O'Callaghan N; Buchanan DD; Clendenning M; Giles GG; Hopper JL; Wong EM; Southey MC
    PLoS One; 2016; 11(11):e0165436. PubMed ID: 27902704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer.
    Lobanova O; Medvedieva N; Fishchuk L; Dubitska O; Cheshuk V; Vereshchako R; Zakhartseva L; Rossokha Z; Gorovenko N
    Breast Cancer Res Treat; 2022 Dec; 196(3):505-515. PubMed ID: 36284026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
    Harahap WA; Sudji IR; Nindrea RD
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
    Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
    JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.